Mitoxantrone Disrupts ERα Function via DBD-LBD Interface Tar
2026-07-24
Wang et al. reveal that mitoxantrone, classically a DNA topoisomerase II inhibitor, can allosterically disrupt estrogen receptor α (ERα) function by targeting the interface between its DNA-binding and ligand-binding domains. This mechanism leads to rapid proteasomal degradation of ERα—including therapy-resistant mutants—offering a new direction for overcoming endocrine resistance in luminal breast cancer.
Butylated Hydroxyanisole (BHA): Mechanisms, Precision, and F
2026-07-24
Explore the advanced mechanistic insights and practical considerations of Butylated Hydroxyanisole (BHA) in oxidative stress research. This resource integrates the latest scientific findings with a focus on BHA’s role as a synthetic antioxidant, offering unique assay guidance beyond standard protocols.
Frizzled5 Links Cholesterol Metabolism to Wnt Signaling in C
2026-07-23
This study reveals that the Frizzled5 receptor uniquely binds cholesterol, promoting its maturation and trafficking via palmitoylation and thereby enabling Wnt/β-catenin signaling in pancreatic cancer. The findings clarify a direct molecular connection between aberrant cholesterol metabolism and oncogenic pathway activation, with implications for targeted cancer therapies.
Sodium Orthovanadate: Optimizing Phosphorylation State Workf
2026-07-23
Sodium Orthovanadate (Na3VO4) is the gold-standard reversible inhibitor for preserving protein tyrosyl phosphorylation during cell signaling and kinase assays. This article details advanced workflow enhancements, troubleshooting tips, and cross-domain insights to maximize reproducibility and data fidelity in phosphorylation-dependent research.
Integrating Transcriptomics and Function to Assess Cardiotox
2026-07-22
This study demonstrates that combining transcriptomic and functional data from human iPSC-derived cardiomyocytes enables comprehensive hazard identification of environmental chemicals affecting cardiac health. By systematically analyzing 464 substances, the authors show that both phenotypic and molecular endpoints converge to support robust risk characterization, broadening the utility of in vitro cardiotoxicity testing.
Liproxstatin-1 HCl: Transforming Ferroptosis Translation
2026-07-22
This article unpacks the mechanistic advances in ferroptosis research, centering on mitochondrial calcium’s regulatory axis and the translational leverage provided by Liproxstatin-1 HCl. It guides researchers through the biological rationale, evidence-based protocol parameters, and the competitive landscape, while outlining the future of selective ferroptosis inhibition in acute organ injury models. Key studies are integrated to illustrate actionable experimental strategy and highlight how APExBIO’s Liproxstatin-1 HCl enables rigorous, next-generation investigations.
Helicase A (Dhx9) Orchestrates TH17 Differentiation in Autoi
2026-07-21
This study reveals that the nuclear helicase Dhx9 is essential for T helper 17 (TH17) lineage differentiation by regulating chromatin accessibility and transcriptional programming. The findings delineate a mechanism underlying TH17-driven autoimmunity and suggest potential avenues for targeted therapeutic intervention.
Halazone and Oxidant-Induced Modulation of Sodium Channel In
2026-07-21
This article analyzes a seminal study examining how Halazone and related oxidants alter sodium current inactivation in frog myelinated nerve fibers. The findings challenge prevailing hypotheses regarding amino acid residue involvement, proposing membrane lipid modification as a primary mechanism. These insights have significant implications for neurophysiology and the experimental use of antimicrobial sulfonamide derivatives.
Brassinolide for Plant Growth and Apoptosis Assays: Protocol
2026-07-20
Brassinolide (24-Epibrassinolide) is uniquely positioned as both a plant growth regulator and a precision apoptosis inducer. This guide delivers stepwise workflows, troubleshooting strategies, and practical insights for experimentalists working in plant biology, cancer research, and metabolic disease models using APExBIO’s high-purity Brassinolide.
MDL 28170: Calpain Inhibitor Workflows for Neuroprotection
2026-07-20
MDL 28170, a selective calpain inhibitor from APExBIO, empowers neuroprotection research and apoptosis assays with nanomolar precision and blood-brain barrier permeability. This guide translates cutting-edge findings and robust protocols into actionable strategies for maximizing experimental reproducibility across neurodevelopmental, ischemic, and infection models.
MVC Disrupts Tight Junctions via RhoA/ROCK1 Pathway Activati
2026-07-19
Ren et al. demonstrate that Minute Virus of Canines (MVC) exploits the RhoA/ROCK1/MLC2 signaling cascade to destabilize epithelial tight junctions, facilitating viral entry through occludin exposure. These findings reveal a direct interaction between viral and host cell machinery, offering new targets for antiviral intervention and deepening our understanding of parvoviral pathogenesis.
EdU Imaging Kits (HF488): Advancing Quantitative Cell Prolif
2026-07-18
Unlock advanced cell proliferation analysis with EdU Imaging Kits (HF488). Explore unique insights into DNA synthesis measurement, innovative click chemistry detection, and applications in drug sensitivity studies.
Optimizing Cell Assays with Dorsomorphin (Compound C) SKU B3
2026-07-17
This article dissects real-world laboratory challenges in AMPK and BMP pathway research, showing how Dorsomorphin (Compound C) (SKU B3252) delivers robust, reproducible inhibition for cell viability, autophagy, and signaling assays. Practical Q&A scenarios, grounded in literature and direct workflow experience, guide scientists in maximizing assay reliability and interpretability.
ML365: Mechanistic Breakthroughs and Translational Guidance
2026-07-17
This thought-leadership article explores the mechanistic foundations and translational strategies associated with ML365, a highly selective inhibitor of the TASK1 potassium channel. Drawing on recent neurophysiology research, it contextualizes ML365's role in modulating NLRP3 inflammasome activation, critically evaluates experimental best practices, and provides actionable insights for target validation and workflow optimization in ion channel pharmacology. The discussion uniquely extends beyond standard product summaries by bridging cutting-edge mechanistic evidence with strategic guidance for translational researchers.
O-GlcNAcylation Regulates Ferroptosis and Syncytialization i
2026-07-16
This study reveals a mechanistic link between O-GlcNAc modification and the regulation of ferroptosis and trophoblast syncytialization in preeclampsia. By identifying HUWE1-mediated ubiquitination of TfR1 as a key axis, the research provides actionable insights for reproductive and placental biology.
507 records 14/34 page Previous Next First page 上5页 1112131415 下5页 Last page